IRIS
PEPE, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.188
AS - Asia 2.828
EU - Europa 2.271
SA - Sud America 361
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 8.738
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.074
SG - Singapore 1.303
RU - Federazione Russa 994
VN - Vietnam 585
CN - Cina 501
UA - Ucraina 297
BR - Brasile 289
IT - Italia 269
HK - Hong Kong 227
DE - Germania 202
FI - Finlandia 115
FR - Francia 100
NL - Olanda 83
CA - Canada 72
IE - Irlanda 61
GB - Regno Unito 60
IN - India 42
SE - Svezia 42
JP - Giappone 34
AR - Argentina 30
CI - Costa d'Avorio 28
MX - Messico 24
ZA - Sudafrica 21
BD - Bangladesh 20
IQ - Iraq 18
EC - Ecuador 13
PH - Filippine 13
PL - Polonia 13
TR - Turchia 12
KR - Corea 10
TH - Thailandia 10
AT - Austria 8
ID - Indonesia 8
VE - Venezuela 8
CO - Colombia 7
PK - Pakistan 7
TW - Taiwan 7
EG - Egitto 6
ES - Italia 6
MA - Marocco 6
CL - Cile 5
AU - Australia 4
HN - Honduras 4
LB - Libano 4
LT - Lituania 4
PS - Palestinian Territory 4
PY - Paraguay 4
BE - Belgio 3
CH - Svizzera 3
EU - Europa 3
NG - Nigeria 3
RS - Serbia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
GF - Guiana Francese 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
QA - Qatar 2
SI - Slovenia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BS - Bahamas 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DK - Danimarca 1
ET - Etiopia 1
GH - Ghana 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KI - Kiribati 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LY - Libia 1
MK - Macedonia 1
MQ - Martinica 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.737
Salva come PNG Salva come JPEG
Città #
Singapore 570
San Jose 470
Ashburn 268
Jacksonville 265
Moscow 255
Woodbridge 232
Hong Kong 225
Beijing 216
Chandler 184
Ho Chi Minh City 181
Hanoi 119
Millbury 115
Los Angeles 83
Santa Clara 78
Princeton 76
Ann Arbor 74
Munich 74
Amsterdam 72
The Dalles 72
Lauterbourg 66
Houston 54
New York 46
Buffalo 44
Wilmington 44
Nanjing 32
Da Nang 28
Milan 26
Tokyo 26
Naples 25
Haiphong 24
Montreal 24
Seattle 24
São Paulo 24
Hefei 23
Ottawa 23
Boston 22
Helsinki 20
Frankfurt am Main 18
Turku 18
Dallas 16
Mexico City 16
Shenyang 16
Atlanta 15
Orem 14
Cagliari 12
Rome 12
Warsaw 12
Bologna 11
Falkenstein 11
Nanchang 11
Brooklyn 10
Chennai 10
Hải Dương 10
Norwalk 10
Orange 10
Stockholm 10
Toronto 10
Washington 10
Can Tho 9
Council Bluffs 9
London 9
Napoli 9
Ninh Bình 9
Poplar 9
Belo Horizonte 8
Denver 8
Dong Ket 8
Johannesburg 8
Phoenix 8
Rio de Janeiro 8
San Francisco 8
Baghdad 7
Boardman 7
Boydton 7
Brasília 7
Hebei 7
Manchester 7
New Delhi 7
Biên Hòa 6
Casoria 6
Charlotte 6
Mumbai 6
Piracicaba 6
Buenos Aires 5
Chicago 5
Falls Church 5
Indiana 5
Kronberg 5
Kunming 5
Long Xuyen 5
Newark 5
Porto Alegre 5
Quận Bình Thạnh 5
Tianjin 5
Ankara 4
Bắc Ninh 4
Castellammare di Stabia 4
Catania 4
Des Moines 4
Dublin 4
Totale 4.734
Salva come PNG Salva come JPEG
Nome #
Manuale di Oncologia Clinica 234
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 195
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-a genes on in vitro transformation of human mammary epithelial cells. 150
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 145
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells. 143
Malignant melanoma Clustering with some familial/hereditary tumors 142
Critical role of both p27kip1 and p21cip1/waf1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. 140
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling 139
Retrospective Analysis of Familial Clustering for Malignant Melanoma 138
Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. 137
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide. 137
The cancer spectrum related to hereditary and familial breast and ovarian cancers 137
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies 136
Regulation of the expression of the low-affinity IgE receptor (FceRII) in the human monocyte-like cell line U-937 by phorbol esters and IgE. 136
Recombinant IFN-alfa 2b treatment activates poly (ADPR) polymerase-1 (PARP-1) in KB cancer cells. 134
Phorbol-12-myristate-13-acetate (PMA) induces resistance of human melanoma cells to NK and LAK-mediated cytotoxicity. 130
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study 129
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway death is antagonized by epidermal growth factor. 129
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. 129
Enzastaurin inhibits tumors sensitive and resistant to anti-EGFR drugs 129
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. 126
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors. 121
Epidermal growth factor (EGFR) and Transferrin (TRFR) receptor upregulation is induced by arabinoside cytosine (ARA-C) on human tumor cells. 120
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells. 119
Mitozolomide activity on human cancer cells "in vitro". 117
Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A. 115
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 115
Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the b1 integrin profile of cultured human tumor cells. 114
NM23 gene expression correlates with cell growth rate and S-phase. 114
Poly(ADPR)polymerase-1 signalling of the DNA damage induced by DNA topoisomerase I poison in D54p53wt and U251p53mut glioblastoma cell lines. 112
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up. 112
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 112
Correlation between bevacizumab-related hypertension and response in mCRC patients 111
Breast cancer prevention with fenretinide in young women at gentic and familial risk. A phase III randomized clinical trial 110
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 109
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. 108
Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype 106
Antisense-protein kinase A: a single-gene-based therapeutic approach. 105
DNA index of ovarian carcinomas from 56 different patients: in vivo, in vitro studies. 105
p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. 104
Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells. 104
Società Italiana di Citofluorimetria (GIC) 104
The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. 103
BRAF is a therapeutic target in aggressive thyroid carcinoma. 103
Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells. 102
In vitro cytotoxicity of VP-16213 on human ovarian cancer. 101
Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents. 101
Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase C beta inhibitor, in non-small cell lung cancer cells. 101
POLY (ADP-RIBOSE) POLYMERASE (PARP-1) EXPRESSION IN MALIGNANT MELANOMAS FROM PHOTO EXPOSED AREAS OF THE HEAD AND NECK REGION 100
Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. 99
Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells. 98
Synergistic anti-tumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells. 96
In vitro and in vivo cytotoxicity of possible uracil metabolites of methylxanthines. 96
Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells. 95
Flow cytometric analysis of DNA content in human ovarian cancer. 94
Loss of thyrotropin regulation and trasforming growth factor beta-induced growth arrest in erbB-2 overexpressing rat thyroid cells. 94
Markers of cell proliferation as prognostic factors in differentiated thyroid cancer. 91
Differential sensitivity to non-MHC-restricted rIL-2 activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or PKA subunits. 91
Studio osservazionale sorveglianza diagnostica di donne ad alto rischio genetico-familiare di tumore mammario (ISSIN-HIBCR) 91
The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014 91
Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture. 90
Quality control for the evaluation of the S-phase fraction by flow cytometry: a multicentric study. 90
cAMP-dependent protein kinase: role in normal and malignant growth. 87
EGF activates an inducible survival response via the RAS -> Erk-1/2 pathway to counteract interferon-alfa-mediated apoptosis in epidermoid cancer cells. 87
8-Chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells 86
TGFb inhibits rat thyroid cell proliferation without alterations in the expression of THS-induced cell cycle-related genes. Vol :pp , 83
Hereditary and familial breast and ovarian cancer: spectrum of related tumors. 82
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells. 81
Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting Protein Kinase A in combination with docetaxel and anti-EGFR-Receptor antibody on human breast cancer cell growth. 81
The cAMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. 81
Fine needle cytology, infectious diseases and non-Hodgkin lymphoma 81
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study. 80
A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. 80
Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment. 78
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-A in head and neck cancer cells in vitro and in vivo 77
Phase I clinical study with 8-Chloro-cAMP and evaluation of immunological effects in cancer patients. 77
Differential effects of type I and type II protein kinase A isoforms on chinese hamster ovary cell cycle and proliferation. 74
New biomolecular prognostic and predictive factors of response to treatments in colorectal cancer 70
Le neoplasie eredo-familiari della mammella, dell'ovaio e del colon retto. Aspetti clininci, diagnostici e teraputici. 59
TSH-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cAMP-dependent protein kinase 56
Retroviral vector-mediated overexpression of the RIIbeta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts. 55
The RIalfa subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. 52
Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. 33
null 26
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy 5
Totale 8.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.054
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022434 8 1 2 1 2 23 3 17 61 42 112 162
2022/2023469 85 41 14 18 49 54 7 33 59 71 34 4
2023/2024423 13 61 29 44 28 47 10 82 0 11 66 32
2024/20252.138 96 105 12 18 46 96 264 153 133 222 805 188
2025/20263.973 484 264 362 377 701 194 480 206 515 266 101 23
Totale 8.850